6 pending office actions • 3 clients
| Client (Assignee) | Pending OAs |
|---|---|
| 4D Molecular Therapeutics Inc. | 4 |
| Pierson Capital Environmental (Beijing) Limited | 1 |
| The University of Warwick | 1 |
| App # | Title | Client | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|---|
| 19301643 | Untitled | 4D Molecular Therapeutics Inc. | MARVICH, MARIA | 1634 | Non-Final OA | |
| 19268429 | EFFICIENT METHODS AND COMPOSITIONS FOR RECOVERY OF PRODUCTS FROM ORGANIC ACID PRETREATMENT OF PLANT MATERIALS | Pierson Capital Environmental (Beijing) Limited | SMITH, JENNIFER A | 1731 | Non-Final OA | Jul 14, 2025 |
| 18466517 | ADENO-ASSOCIATED VIRUS VARIANT CAPSIDS AND USE FOR INHIBITING ANGIOGENESIS | 4D Molecular Therapeutics Inc. | NICOL, ALEXANDER W | 1634 | Non-Final OA | Sep 13, 2023 |
| 18042517 | CODON OPTIMIZED RPGRORF15 GENES AND USES THEREOF | 4D Molecular Therapeutics Inc. | MCCORMICK, CATHERINE LYNN | 1638 | Non-Final OA | Feb 22, 2023 |
| 18052735 | CODON OPTIMIZED REP1 GENES AND USES THEREOF | 4D Molecular Therapeutics Inc. | ARON, KIMBERLY A | 1633 | Non-Final OA | Nov 04, 2022 |
| 17613911 | LEADER SEQUENCE | The University of Warwick | ZEMAN, ROBERT A | 1645 | Final Rejection | Nov 23, 2021 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial